Aker BioMarine AS (OSL: AKBM)

Aker BioMarine AS Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	5,761	4,033	3,335	4,756	10,291	-
Market Cap Growth	25.08%	20.94%	-29.89%	-53.79%	-	-
Enterprise Value	7,186	8,170	7,246	7,421	12,373	-
Last Close Price	65.70	25.59	21.16	30.20	65.36	-
PE Ratio	207.98	-	33.85	-	-	-
Forward PE	175.54	80.57	30.13	-	26.43	-
PS Ratio	1.62	1.19	1.22	2.06	4.16	-
PB Ratio	2.88	1.09	0.89	1.46	3.22	-
P/TBV Ratio	4.69	1.85	1.54	2.68	6.23	-
P/FCF Ratio	37.47	265.14	-	-	-	-
P/OCF Ratio	7.89	8.39	22.42	207.63	-	-
EV/Sales Ratio	2.04	2.40	2.65	3.21	5.00	-
EV/EBITDA Ratio	14.07	16.15	12.04	21.88	29.02	-
EV/EBIT Ratio	125.47	138.91	45.12	-	165.60	-
EV/FCF Ratio	46.74	537.11	-	-	-	-
Debt / Equity Ratio	0.79	1.07	1.01	0.88	0.65	2.72
Debt / EBITDA Ratio	2.92	7.20	5.82	7.37	4.33	9.10
Debt / FCF Ratio	10.29	262.00	-	-	-	-
Asset Turnover	0.55	0.41	0.35	0.36	0.41	0.44
Inventory Turnover	1.54	1.17	0.97	1.38	1.68	2.18
Quick Ratio	1.24	0.83	0.83	0.92	1.05	0.64
Current Ratio	3.68	2.57	2.85	3.10	3.15	1.83
Return on Equity (ROE)	0.95%	-2.42%	2.67%	-2.15%	-2.07%	-14.25%
Return on Assets (ROA)	0.47%	0.44%	1.29%	-0.59%	0.78%	1.04%
Return on Capital (ROIC)	0.52%	0.48%	1.40%	-0.66%	0.92%	1.21%
Earnings Yield	50.38%	-2.26%	2.95%	-1.48%	-0.45%	-
FCF Yield	3.57%	0.38%	-7.50%	-14.10%	-6.05%	-
Buyback Yield / Dilution	0.87%	-0.04%	-0.05%	-12.20%	-13.05%	-
Total Shareholder Return	0.87%	-0.04%	-0.05%	-12.20%	-13.05%	-

Source: S&P Capital IQ. Standard template. Financial Sources.